287
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Pre-eclampsia: incidence, determinants, and pregnancy outcomes from maternity hospitals in Qatar: a population-based case-control study

, , , , &
Pages 7831-7839 | Received 22 Jan 2021, Accepted 30 May 2021, Published online: 10 Jun 2021

References

  • Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112. [published correction appears in Circ Res. 2020;126(1):e8].
  • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
  • Kuklina EV, Ayala C, Callaghan WM, et al. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–1306.
  • Task Force on Hypertension in Pregnancy. Hypertension in pregnancy 2013. Washington (DC): American College of Obstetricians and Gynecologists; 2013.
  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
  • Lawn JE, Blencowe H, Waiswa P, et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016;387:587–603.
  • Knight M, Bunch K, Tuffnell D, et al. 2019. Saving lives, improving mothers’ care: Lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2015–17. https://www.npeu.ox.ac.uk/assets/downloads/mbrrace-uk/reports/MBRRACE-UK%20Maternal%20Report%202019%20-%20WEB%20VERSION.pdf
  • Nyfløt LT, Ellingsen L, Yli BM, et al. Maternal deaths from hypertensive disorders: lessons learnt. Acta Obstet Gynecol Scand. 2018; 97:976–987.
  • Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99(7):547–553.
  • New estimates of maternal mortality. Week Epidemiol Rec. 1996;71(13):97–100.
  • Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979–988.
  • Broekhuijsen K, van Baaren GJ, van Pampus MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial [published correction appears in Lancet. 2016 Feb 27;387(10021):848. ]. Lancet. 2015;385(9986):2492–2501.
  • CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343(8898):619–629.
  • Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG. 2007;114(3):300–309.
  • ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
  • Wu P, Haththotuwa R, Kwok C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497.
  • Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009; 53:944–951.
  • Hovsepian DA, Sriram N, Kamel H, et al. Acute cerebrovascular disease occurring after hospital discharge for labor and delivery. Stroke. 2014; 45:1947–1950.
  • Collier CH, Martin JN. Jr. Hypertensive disorders of pregnancy. [cited 2018 May 10]. http://www.contemporaryobgyn.net/authors/james-n-martin-jr-md-facog-frcog-faha.
  • Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366:l5119.
  • Sandhu AK, Mustafa FE. Maternal mortality in Bahrain 1987–2004: an audit of causes of avoidable death. East Mediterr Health J. 2008;14(3):720–730.
  • Legnain M, Singh R, Busarira MO. Maternal mortality in Benghazi: a clinicoepidemiological study. East Mediterr Health J. 2000;6(2–3):283–292.
  • Mönckeberg M, Arias V, Fuenzalida R, et al. Diagnostic performance of first trimester screening of preeclampsia based on uterine artery pulsatility index and maternal risk factors in routine clinical use. Diagnostics. 2020;10(4):182.
  • Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):14–24.
  • Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
  • Belay AS, Wudad T. Prevalence and associated factors of pre-eclampsia among pregnant women attending anti-natal care at Mettu Karl Referal Hospital, Ethiopia: cross-sectional study. Clin Hypertens. 2019;25:14.
  • Hernández-Díaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338:b2255.
  • Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
  • Mor M, Shmueli A, Krispin E, et al. Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia. Arch Gynecol Obstet. 2020;301(3):655–664.
  • Raz Y, Lavie A, Vered Y, et al. Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. Am J Obstet Gynecol. 2015;213(3):395.e1-395–395.e8.e3958.
  • Sharara HA, Shaikh N, Ummunnisa F, et al. Changes in trends and outcomes of eclampsia: a success story from Qatar. Qatar Medi J. 2019;2019(1):10.
  • Maducolil MK, Abid H, Lobo RM, et al. Risk factors and classification of stillbirth in a Middle Eastern population: a retrospective study. J Perinat Med. 2018;46(9):1022–1027.
  • Hirst JE, Villar J, Victora CG, et al. The International Fetal and newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). The antepartum stillbirth syndrome: risk factors and pregnancy conditions identified from the INTERGROWTH-21st Project. Br J Obstet Gynaecol. 2016;125(9):1145–1153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.